Accuracy of automatic abnormal potential annotation for substrate identification in scar-related ventricular tachycardia.

catheter ablation double potential fragmented potential high-resolution mapping late potential local abnormal ventricular activities ventricular tachycardia

Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
08 2021
Historique:
revised: 28 04 2021
received: 23 02 2021
accepted: 31 05 2021
pubmed: 6 7 2021
medline: 21 10 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

Ultrahigh-density mapping for ventricular tachycardia (VT) is increasingly used. However, manual annotation of local abnormal ventricular activities (LAVAs) is challenging in this setting. Therefore, we assessed the accuracy of the automatic annotation of LAVAs with the Lumipoint algorithm of the Rhythmia system (Boston Scientific). One hundred consecutive patients undergoing catheter ablation of scar-related VT were studied. Areas with LAVAs and ablation sites were manually annotated during the procedure and compared with automatically annotated areas using the Lumipoint features for detecting late potentials (LP), fragmented potentials (FP), and double potentials (DP). The accuracy of each automatic annotation feature was assessed by re-evaluating local potentials within automatically annotated areas. Automatically annotated areas matched with manually annotated areas in 64 cases (64%), identified an area with LAVAs missed during manual annotation in 15 cases (15%), and did not highlight areas identified with manual annotation in 18 cases (18%). Automatic FP annotation accurately detected LAVAs regardless of the cardiac rhythm or scar location; automatic LP annotation accurately detected LAVAs in sinus rhythm, but was affected by the scar location during ventricular pacing; automatic DP annotation was not affected by the mapping rhythm, but its accuracy was suboptimal when the scar was located on the right ventricle or epicardium. The Lumipoint algorithm was as/more accurate than manual annotation in 79% of patients. FP annotation detected LAVAs most accurately regardless of mapping rhythm and scar location. The accuracy of LP and DP annotations varied depending on mapping rhythm or scar location.

Identifiants

pubmed: 34223662
doi: 10.1111/jce.15148
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2216-2224

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Santangeli P, Frankel DS, Tung R, et al, International VT Ablation Center Collaborative Group. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol. 2017;69:2105-2115.
Tung R, Vaseghi M, Frankel DS, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12:1997-2007.
Jaïs P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125:2184-2196.
Sacher F, Lim HS, Derval N, et al. Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol. 2015;26:464-471.
Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13:569-583.
Cassidy DM, Vassallo JA, Buxton AE, Doherty JU, Marchlinski FE, Josephson ME. The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia. Circulation. 1984;69:1103-1110.
Soejima K, Suzuki M, Maisel WH, et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation. 2001;104:664-669.
Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolution mapping of postinfarction reentrant ventricular tachycardia: electrophysiological characterization of the circuit. Circulation. 2016;134:314-327.
Martin R, Hocini M, Haïsaguerre M, Jaïs P, Sacher F. Ventricular tachycardia isthmus characteristics: insights from high-density mapping. Arrhythm Electrophysiol Rev. 2019;8:54-59.
Martin CA, Takigawa M, Martin R, et al. Use of novel electrogram "Lumipoint" algorithm to detect critical isthmus and abnormal potentials for ablation in ventricular tachycardia. JACC Clin Electrophysiol. 2019;5:470-479.
Frontera A, Melillo F, Baldetti L, et al. High-density characterization of the ventricular electrical substrate during sinus rhythm in post-myocardial infarction patients. JACC Clin Electrophysiol. 2020;6:799-811.
Takigawa M, Martin CA, Derval N, et al. Insights from atrial surface activation throughout atrial tachycardia cycle length: a new mapping tool. Heart Rhythm. 2019;16:1652-1660.
Alken FA, Klatt N, Muenkler P, et al. Advanced mapping strategies for ablation therapy in adults with congenital heart disease. Cardiovasc Diagn Ther. 2019;9:S247-S263.
Solimene F, Maddaluno F, Malacrida M, Schillaci V. Pseudo-reentry due to automatic annotation of dissociated activity unmasked by the new Lumipoint™ algorithm. Clin Case Rep. 2019;8:38-40.
Bisceglia C, Frontera A, Della Bella P. The LUMIPOINT™ software: are we just at the turning point? Europace. 2019;21:iii25-iii26.
de Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation. 1993;88:915-926.

Auteurs

Yosuke Nakatani (Y)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Philippe Maury (P)

Unité Inserm U 1048, University Hospital Rangueil, Toulouse, France.

Anne Rollin (A)

Unité Inserm U 1048, University Hospital Rangueil, Toulouse, France.

F Daniel Ramirez (FD)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Cyril Goujeau (C)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Takashi Nakashima (T)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Clémentine André (C)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Aline Carapezzi (A)

Boston Scientific, France.

Philipp Krisai (P)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Takamitsu Takagi (T)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Tsukasa Kamakura (T)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Konstantinos Vlachos (K)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Ghassen Cheniti (G)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Romain Tixier (R)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Quentin Voglimacci-Stefanopoli (Q)

Unité Inserm U 1048, University Hospital Rangueil, Toulouse, France.

Nicolas Welte (N)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Remi Chauvel (R)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Josselin Duchateau (J)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Thomas Pambrun (T)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Nicolas Derval (N)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Mélèze Hocini (M)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Michel Haïssaguerre (M)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Pierre Jaïs (P)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Frédéric Sacher (F)

Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, University Hospital (CHU), University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH